For the quarter ended December 2023, Avantor, Inc. (AVTR) reported revenue of $1.72 billion, down 4% over the same period last year. EPS came in at $0.25, compared to $0.32 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.69 billion, representing a surprise of +1.65%. The company delivered an EPS surprise of +13.64%, with the consensus EPS estimate being $0.22.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stre ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ━━━━━━━━━ FORM 10-K ━━━━━━━━━ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-38912 Avantor, Inc. (Exact name of registrant as specified in its charter) Delaware 82-2758923 (State or ...

Analysts on Wall Street project that Avantor, Inc. (AVTR) will announce quarterly earnings of $0.22 per share in its forthcoming report, representing a decline of 31.3% year over year. Revenues are projected to reach $1.69 billion, declining 5.6% from the same quarter last year.Over the last 30 days, there has been a downward revision of 3.4% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecast ...

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Avantor, Inc. (AVTR) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, ...

RADNOR, Pa., Jan. 24, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February, 14, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.To hear a live audio webcast of the session, visit Events ...

RADNOR, Pa., Jan. 19, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, kicked off the year at the 2024 Americas Sales Conference in Orlando, Fla. The event brought together attendees representing the Americas sales organization and suppliers, with a focus on collaboration and advancing solutions to serve customers. Avantor® Recognizes Supplier Award Winners at 2024 Americas Sal ...

Q3 2023 Earnings EARNINGS PRESENTATION October 27, 2023 ...

Avantor, Inc. (NYSE:AVTR) Q3 2023 Earnings Conference Call October 27, 2023 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President & CEO Brent Jones - EVP & CFO Conference Call Participants Daniel Brennan - TD Cowen Vijay Kumar - Evercore ISI Jack Meehan - Nephron Research Michael Ryskin - Bank of America Patrick Donnelly - Citi Rachel Vatnsdal - JPMorgan Luke Sergott - Barclays Daniel Leonard - UBS Catherine Schulte - Robert W. Baird Operator Good morning. My name is Emil ...

Financial Performance - Net sales for the three months ended September 30, 2023, were $1,720.2 million, a decrease of $136.3 million or 7.3% compared to the same period in 2022[108][117]. - Organic net sales declined by $178.4 million or 9.6%, with a decline of 7.9% when excluding the impact of COVID-19-related products[119]. - Adjusted EBITDA for the third quarter was $317.8 million, down from $384.0 million in the prior year, reflecting a decrease of $66.2 million[117]. - Operating income for the three months ended September 30, 2023, was $210.2 million, a decrease of $65.6 million or 23.8% compared to $275.8 million for the same period in 2022[130][134]. - For the nine months ended September 30, 2023, operating income was $513.1 million, down $365.3 million or 41.6% from $878.4 million in the prior year[130][134]. - Adjusted EBITDA for the three months ended September 30, 2023, was $317.8 million, a decline of $66.2 million or 17.2% compared to $384.0 million in the same period last year[137][138]. - The nine-month Adjusted EBITDA decreased by $204.2 million or 16.9%, totaling $1,007.0 million compared to $1,211.2 million in the previous year[137][139]. - Net income for the nine months ended September 30, 2023, was $222.6 million, a decrease of $322.2 million compared to $544.8 million in the same period of 2022[152]. Regional Sales Performance - In the Americas, net sales decreased by $104.0 million or 9.3%, with organic net sales down by $105.0 million or 9.4%[120]. - In Europe, net sales decreased by $15.3 million or 2.6%, with organic net sales down by $56.4 million or 9.5%[121]. - In AMEA, net sales decreased by $17.0 million or 12.3%, with organic net sales also down by $17.0 million or 12.3%[123]. - The Americas region saw a decline in Adjusted EBITDA of $38.5 million or 14.7% for the three months ended September 30, 2023[138][140]. - In Europe, Adjusted EBITDA decreased by $27.4 million or 21.0% for the same period, driven by sales volume contraction[139][140]. Cost and Margin Analysis - Gross margin contracted to 33.6% for the three months ended September 30, 2023, down from 35.0% in the same period last year, a decline of 140 basis points[128]. - The company experienced inflationary pressures across all cost categories, impacting overall financial performance[111]. - The decline in sales was attributed to reduced customer demand, customer destocking, and the ongoing effects of the COVID-19 pandemic[118]. Cash Flow and Liquidity - Cash generated from operating activities for the three months ended September 30, 2023, was $230.7 million, while for the nine months, it was $618.4 million[145]. - The company ended the quarter with $236.9 million in cash and cash equivalents, with total liquidity amounting to $1,224.6 million[148][149]. - Cash flows from operating activities decreased by $19.6 million in 2023, primarily due to lower net income, despite improved working capital[153]. - Free cash flow was $522.6 million for the nine months ended September 30, 2023, down $15.6 million from $538.2 million in the prior year[155]. - Non-cash items increased to $475.3 million in 2023 from $350.5 million in 2022, reflecting higher depreciation and amortization[152]. - Working capital changes improved by $145.1 million, with a change from $(155.1) million in 2022 to $(10.0) million in 2023[152]. Impairments and Debt - The company recorded impairment charges of $160.8 million during the nine months ended September 30, 2023[130][132]. - There were no debt repayments due in the next twelve months other than required term loan payments of $32.8 million and receivables facility borrowing of $297.7 million[145]. Investment and Financing Activities - Investing activities used $17.2 million more cash in 2023, mainly due to the absence of cross currency swap settlement and acquisition activity[153]. - Financing activities resulted in $92.5 million more cash used in 2023, primarily due to net repayments on the receivables facility compared to net borrowings in 2022[153]. - Capital expenditures decreased slightly to $95.8 million in 2023 from $99.8 million in 2022, contributing to the reduction in free cash flow[155]. Accounting and Market Risk - There were no new accounting standards expected to materially impact the financial position or results of operations[157]. - No significant changes to market risk disclosures were reported in the Annual Report[158].

Avantor, Inc. (NYSE:AVTR) Q2 2023 Earnings Conference Call July 28, 2023 8:00 AM ET Company Participants Christina Jones - Vice President, Investor Relations Michael Stubblefield - President & Chief Executive Officer Tom Szlosek - Executive Vice President & Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Michael Ryskin - Bank of America Luke Sergott - Barclays Vijay Kumar - Evercore ISI Rachel Vatnsdal - JPMorgan Matt Sykes - Goldman Sachs Patrick Donnelly - Citi Justin Bo ...